X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7547) 7547
Newsletter (251) 251
Newspaper Article (67) 67
Magazine Article (36) 36
Dissertation (15) 15
Book Chapter (14) 14
Web Resource (8) 8
Conference Proceeding (6) 6
Paper (3) 3
Book / eBook (2) 2
Book Review (2) 2
Publication (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
amlodipine (5061) 5061
humans (3839) 3839
male (2924) 2924
hypertension - drug therapy (2442) 2442
female (2395) 2395
hypertension (2350) 2350
middle aged (2109) 2109
amlodipine - therapeutic use (1865) 1865
aged (1656) 1656
antihypertensive agents - therapeutic use (1489) 1489
blood pressure - drug effects (1480) 1480
pharmacology & pharmacy (1411) 1411
adult (1249) 1249
calcium channel blockers - therapeutic use (1167) 1167
peripheral vascular disease (1104) 1104
treatment outcome (1016) 1016
amlodipine - administration & dosage (990) 990
drug therapy, combination (974) 974
animals (958) 958
amlodipine - pharmacology (951) 951
hypertension - physiopathology (907) 907
cardiac & cardiovascular systems (848) 848
blood-pressure (796) 796
antihypertensive agents - administration & dosage (747) 747
amlodipine - adverse effects (743) 743
calcium channel blockers - pharmacology (730) 730
blood pressure (715) 715
double-blind method (681) 681
valsartan (638) 638
drug therapy (563) 563
rats (562) 562
antihypertensive agents - adverse effects (547) 547
hypertension - complications (540) 540
drug combinations (514) 514
hydrochlorothiazide (506) 506
calcium channel blockers - administration & dosage (496) 496
medicine, general & internal (457) 457
nifedipine (456) 456
calcium channel blockers - adverse effects (449) 449
research (449) 449
amlodipine besylate (437) 437
tetrazoles - therapeutic use (425) 425
antihypertensive agents - pharmacology (422) 422
calcium channel blockers (422) 422
dose-response relationship, drug (418) 418
mortality (415) 415
time factors (413) 413
risk factors (408) 408
prevention (385) 385
prospective studies (377) 377
therapy (376) 376
dosage and administration (367) 367
double-blind (367) 367
angiotensin-converting enzyme inhibitors - therapeutic use (364) 364
efficacy (347) 347
analysis (338) 338
aged, 80 and over (333) 333
risk (333) 333
disease (317) 317
management (317) 317
pharmacokinetics (317) 317
heart rate - drug effects (310) 310
outcomes (307) 307
care and treatment (304) 304
drugs (304) 304
calcium channel blocker (298) 298
chemistry, analytical (291) 291
trial (291) 291
combination therapy (290) 290
angiotensin ii type 1 receptor blockers - therapeutic use (285) 285
antihypertensive drugs (285) 285
medicine & public health (270) 270
tetrazoles - administration & dosage (263) 263
blood pressure monitoring, ambulatory (262) 262
diuretics (262) 262
valine - analogs & derivatives (262) 262
internal medicine (260) 260
cardiovascular events (253) 253
hydrochlorothiazide - therapeutic use (252) 252
losartan (245) 245
follow-up studies (239) 239
randomized controlled trials as topic (239) 239
medicine, research & experimental (238) 238
hypertensive patients (233) 233
health aspects (228) 228
atherosclerosis (224) 224
adolescent (223) 223
atorvastatin (220) 220
amlodipine - pharmacokinetics (219) 219
cross-over studies (215) 215
combination (214) 214
calcium (213) 213
atenolol (210) 210
blood pressure - physiology (207) 207
hypertension - diagnosis (205) 205
cardiology (203) 203
arterial hypertension (201) 201
clinical trials (199) 199
tablets (198) 198
nifedipine - analogs & derivatives (197) 197
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7443) 7443
Russian (270) 270
German (115) 115
Japanese (112) 112
Spanish (63) 63
French (59) 59
Portuguese (43) 43
Chinese (42) 42
Polish (34) 34
Korean (25) 25
Hungarian (21) 21
Italian (21) 21
Czech (16) 16
Ukrainian (10) 10
Croatian (5) 5
Norwegian (5) 5
Danish (4) 4
Slovak (4) 4
Swedish (4) 4
Dutch (3) 3
Turkish (3) 3
Arabic (2) 2
Bosnian (2) 2
Serbian (2) 2
Slovenian (2) 2
Hebrew (1) 1
Indonesian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of emergency medicine, ISSN 0196-0644, 10/2016, Volume 68, Issue 4, p. S128-S129
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.annemergmed.2016.08.352 Byline: J.M. LeRoy, S.P. Boley, K.M.... 
Amlodipine
Journal Article
Journal of Clinical Periodontology, ISSN 0303-6979, 06/2018, Volume 45, Issue S19, pp. 378 - 378
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2010, Volume 32, Issue 7, pp. 1252 - 1269
Abstract Background: Patients with hypertension may require a combination of ≥2 antihypertensive agents to achieve blood pressure (BP) control. Objective: The... 
Internal Medicine | Medical Education | fixed-dose combination therapy | olmesartan medoxomil | blood pressure | antihypertensive therapy | amlodipine besylate | Antihypertensive therapy | Amlodipine besylate | Blood pressure | Olmesartan medoxomil | Fixed-dose combination therapy | METAANALYSIS | COMBINATION THERAPY | PREVENTION | COMMITTEE | ADHERENCE | RESISTANT | HIGH-BLOOD-PRESSURE | PHARMACOLOGY & PHARMACY | OUTCOMES | VALSARTAN | Follow-Up Studies | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Imidazoles - administration & dosage | Hypertension - drug therapy | Male | Tetrazoles - administration & dosage | Adult | Female | Blood Pressure - drug effects | Imidazoles - therapeutic use | Drug Therapy, Combination | Amlodipine - administration & dosage | Olmesartan Medoxomil | Hydrochlorothiazide - adverse effects | Severity of Illness Index | Double-Blind Method | Imidazoles - adverse effects | Amlodipine - adverse effects | Hydrochlorothiazide - administration & dosage | Antihypertensive Agents - therapeutic use | Hypertension - physiopathology | Amlodipine - therapeutic use | Antihypertensive Agents - adverse effects | Tetrazoles - therapeutic use | Aged | Tetrazoles - adverse effects | Hydrochlorothiazide - therapeutic use | Drug Combinations | Hypertension | Medical research | Care and treatment | Diuretics | Amlodipine | Medicine, Experimental | Drug therapy, Combination
Journal Article
American Journal of Cardiovascular Drugs, ISSN 1175-3277, 2008, Volume 8, Issue 1, pp. 51 - 67
Amlodipine/atorvastatin (Caduet®) is a once-daily fixed-dose combination of the dihydropyridine calcium channel antagonist amlodipine and the HMG-CoA reductase... 
Hypertension | Lipid metabolism disorders | Cardiovascular disorders | Amlodipine/atorvastatin | Pharmacotherapy | Medicine & Public Health | Cardiology | Pharmacology/Toxicology | Amlodipine/ atorvastatin, therapeutic use | Hypertension, treatment | Amlodipine/atorvastatin, pharmacodynamics | Amlodipine/atorvastatin, adverse reactions | Cardiovascular disorders, prevention | Amlodipine/atorvastatin, pharmacokinetics | AMLODIPINE-ATORVASTATIN COMBINATION | PHARMACOLOGICAL PROPERTIES | HEART-DISEASE | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | CORONARY ATHEROSCLEROSIS | SINGLE-PILL AMLODIPINE/ATORVASTATIN | RISK | PHARMACOLOGY & PHARMACY | OUTCOMES | LIPID-LOWERING THERAPY | HIGH BLOOD-PRESSURE | Pyrroles - pharmacokinetics | Calcium Channel Blockers - adverse effects | Cardiovascular Diseases - prevention & control | Heptanoic Acids - pharmacokinetics | Humans | Hypertension - drug therapy | Heptanoic Acids - adverse effects | Amlodipine - pharmacokinetics | Drug Interactions | Pyrroles - administration & dosage | Heptanoic Acids - administration & dosage | Pyrroles - adverse effects | Pyrroles - economics | Amlodipine - administration & dosage | Calcium Channel Blockers - economics | Dyslipidemias - drug therapy | Heptanoic Acids - economics | Anticholesteremic Agents - economics | Amlodipine - adverse effects | Clinical Trials as Topic | Anticholesteremic Agents - adverse effects | Atorvastatin Calcium | Anticholesteremic Agents - pharmacokinetics | Anticholesteremic Agents - administration & dosage | Calcium Channel Blockers - administration & dosage | Amlodipine - economics | Calcium Channel Blockers - pharmacokinetics | Drug Combinations | Prevention | Patient outcomes | Amlodipine | Dosage and administration | Research | Drug therapy, Combination | Cardiovascular diseases | Drug therapy | Health aspects
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 2008, Volume 68, Issue 3, pp. 373 - 381
Journal Article
BMC cardiovascular disorders, ISSN 1471-2261, 09/2016, Volume 16, Issue 1, p. 168
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2012, Volume 34, Issue 3, pp. 537 - 551
Abstract Background Hypertensive patients with diabetes often require combination therapy to achieve a blood pressure (BP) goal, and evidence suggests that... 
Internal Medicine | Medical Education | metabolic syndrome | type 2 diabetes mellitus | single-pill combination | telmisartan/amlodipine | hypertension | obesity | Hypertension | Obesity | Single-pill combination | Telmisartan/amlodipine | Type 2 diabetes mellitus | Metabolic syndrome | UNITED-STATES | CARDIOVASCULAR EVENTS | PLUS AMLODIPINE | GUIDELINES | MICROVASCULAR OUTCOMES | CLINICAL EVENTS | UNCONTROLLED HYPERTENSION | HIGH-RISK PATIENTS | EUROPEAN COUNTRIES | PHARMACOLOGY & PHARMACY | AMBULATORY BLOOD-PRESSURE | Benzoates - adverse effects | Antihypertensive Agents - pharmacology | Benzoates - therapeutic use | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Male | Benzimidazoles - administration & dosage | Female | Blood Pressure - drug effects | Benzimidazoles - adverse effects | Hypertension - diagnosis | Amlodipine - administration & dosage | Diabetes Mellitus, Type 2 - complications | Benzimidazoles - therapeutic use | Body Mass Index | Severity of Illness Index | Double-Blind Method | Amlodipine - adverse effects | Treatment Outcome | Antihypertensive Agents - therapeutic use | Amlodipine - therapeutic use | Antihypertensive Agents - adverse effects | Benzoates - administration & dosage | Amlodipine - pharmacology | Benzoates - pharmacology | Hypertension - complications | Benzimidazoles - pharmacology | Aged | Diabetes Mellitus, Type 2 - drug therapy | Drug Combinations | Type 2 diabetes | Diabetics | Amlodipine | Clinical trials | Insulin resistance | Universities and colleges | Diabetes | Body mass index | Mortality | Drug therapy | Pharmaceutical industry | Drug dosages | Metabolic disorders
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2017, Volume 39, Issue 7, pp. 1371 - 1379
Abstract Purpose A fixed-dose combination (FDC) pill of amlodipine (relatively old calcium channel blocker as dihydropyridine) and olmesartan (relatively new... 
Internal Medicine | Medical Education | pharmacokinetics | S-amlodipine | olmesartan | bioequivalence | EFFICACY | DOUBLE-BLIND | BESYLATE | PHARMACOLOGY & PHARMACY | Olmesartan Medoxomil - pharmacokinetics | Tablets | Humans | Male | Healthy Volunteers | Angiotensin II Type 1 Receptor Blockers - pharmacokinetics | Niacin - administration & dosage | Young Adult | Amlodipine - pharmacokinetics | Adult | Amlodipine - administration & dosage | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Niacin - blood | Olmesartan Medoxomil - blood | Olmesartan Medoxomil - administration & dosage | Amlodipine - blood | Cross-Over Studies | Asian Continental Ancestry Group | Calcium Channel Blockers - administration & dosage | Niacin - pharmacokinetics | Angiotensin II Type 1 Receptor Blockers - blood | Calcium Channel Blockers - blood | Calcium Channel Blockers - pharmacokinetics | Drug Combinations | Therapeutic Equivalency | Hypertension | Calcium channels | Analysis | Amlodipine | Dosage and administration | Drug therapy, Combination | Patient compliance | Drugs | Physical examinations | Calcium | Laboratories | Males | Ethics | Mathematical analysis | New combinations | Blood pressure | Safety | Dihydropyridine | Angiotensin II | Product safety | Drug dosages | Formulations | Urine | Test procedures | Data processing | Pharmacology | Bioavailability | Patients | Variance analysis | Hypotension | Angiotensin | Clinical medicine
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 1997, Volume 29, Issue 4, pp. 563 - 580
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 375, Issue 9721, pp. 1173 - 1181
Summary Background The Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial showed that... 
Internal Medicine | AMLODIPINE | MORTALITY | BENAZEPRIL | MEDICINE, GENERAL & INTERNAL | CONVERTING-ENZYME-INHIBITOR | ALBUMINURIA | DISEASE | NITRIC-OXIDE | DIABETIC-NEPHROPATHY | PROGRESSION | Blood Pressure | Calcium Channel Blockers - adverse effects | Benzazepines - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Kidney Failure, Chronic - urine | Male | Albuminuria | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - mortality | Female | Amlodipine - administration & dosage | Hydrochlorothiazide - adverse effects | Kidney Failure, Chronic - physiopathology | Diuretics - administration & dosage | Glomerular Filtration Rate | Double-Blind Method | Risk Factors | Amlodipine - adverse effects | Hydrochlorothiazide - administration & dosage | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Disease Progression | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Calcium Channel Blockers - administration & dosage | Kidney Failure, Chronic - complications | Creatinine - blood | Hypertension - complications | Aged | Benzazepines - administration & dosage | Diuretics - adverse effects | Drug Combinations | Hypertension | Chronic kidney failure | Patient outcomes | Development and progression | Drug therapy, Combination | Drug therapy | Methods | Risk factors | Studies | Heart failure | Blister packs | Mortality | Kidney diseases | Diabetes | Drugs | blood pressure | Side effects | Filtration | secondary analysis | Dialysis | clinical trials | hypertension | Kidney
Journal Article